Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Molecular Cancer Therapeutics|July 27, 2016
Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaYong Qin, Jason Roszik, Chandrani Chattopadhyay, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblastsNatalia Nacu, Irina G Luzina, Kendrick Highsmith, et al.The Journal of Biological Chemistry|February 16, 2012
Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancerMatthew T Riolo, Zachary A Cooper, Michael P Holloway, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activationManisha Singh, Hiep Khong, Zhimin Dai, et al.The Journal of Biological Chemistry|September 10, 2010
Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activityHaijuan Wang, Michael P Holloway, Li Ma, et al.Frontiers in Oncology|March 19, 2026
CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancerInger Johanne Zwicky Eide, Anne Pernille Harlem Dyrbekk, Ina Bisha, et al.Surgery|July 10, 2012
Targeting the MAGE A3 antigen in pancreatic cancerAlexandria P Cogdill, Dennie T Frederick, Zachary A Cooper, et al.Oncoimmunology|November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytesZachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.Cancer Discovery|November 23, 2012
Elucidating distinct roles for NF1 in melanomagenesisOphélia Maertens, Bryan Johnson, Pablo Hollstein, et al.Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.Pageof 9